Page last updated: 2024-09-02

caffeic acid phenethyl ester and Alloxan Diabetes

caffeic acid phenethyl ester has been researched along with Alloxan Diabetes in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (50.00)29.6817
2010's3 (30.00)24.3611
2020's2 (20.00)2.80

Authors

AuthorsStudies
Han, Y; Li, B; Li, Z; Luo, Z; Wan, Q1
Aksu Kızıldağ, C; Albayrak, M; Arabacı, T; Balseven, HM; Kızıldağ, A; Tasdemir, U1
Acquaviva, R; Di Giacomo, C; Intagliata, S; Pittalà, V; Raffaele, M; Salerno, L; Sorrenti, V; Vanella, L1
Abduljawad, SH; El-Nashar, NN; El-Refaei, MF1
Cetin, A; Elbe, H; Gul, M; Ozyalin, F; Taslidere, E; Turkoz, Y; Vardi, N1
Celik, S; Erdogan, S; Tuzcu, M1
Altuntas, I; Ozcelik, N; Uz, E; Yilmaz, HR; Yucel, N1
Okutan, H; Ozcelik, N; Uz, E; Yilmaz, HR1
Min, TS; Park, SH1
Celik, S; Erdogan, S1

Other Studies

10 other study(ies) available for caffeic acid phenethyl ester and Alloxan Diabetes

ArticleYear
CAPE-pNO
    Life sciences, 2021, Dec-15, Volume: 287

    Topics: Alzheimer Disease; Animals; Animals, Outbred Strains; Autophagy; Brain Injuries; Caffeic Acids; Cell Line; Diabetes Mellitus, Experimental; Inflammation; Male; Mice; NF-E2-Related Factor 2; Oxidative Stress; Phenylethyl Alcohol

2021
A biochemical and immunohistochemical study of the effects of caffeic acid phenethyl ester on alveolar bone loss and oxidative stress in diabetic rats with experimental periodontitis.
    Biotechnic & histochemistry : official publication of the Biological Stain Commission, 2020, Volume: 95, Issue:6

    Topics: Alveolar Bone Loss; Animals; Caffeic Acids; Diabetes Mellitus, Experimental; Disease Models, Animal; Male; Oxidative Stress; Periodontitis; Phenylethyl Alcohol; Rats, Wistar; Streptozocin

2020
Protective Effects of Caffeic Acid Phenethyl Ester (CAPE) and Novel Cape Analogue as Inducers of Heme Oxygenase-1 in Streptozotocin-Induced Type 1 Diabetic Rats.
    International journal of molecular sciences, 2019, May-17, Volume: 20, Issue:10

    Topics: Amidohydrolases; Animals; Antioxidants; Caffeic Acids; Diabetes Mellitus, Experimental; Glutamate-Cysteine Ligase; Heme Oxygenase (Decyclizing); Male; Nitric Oxide Synthase Type II; Phenylethyl Alcohol; Propolis; Rats; Rats, Wistar; Streptozocin; Up-Regulation

2019
Protective and anti-angiopathy effects of caffeic acid phenethyl ester against induced type 1 diabetes in vivo.
    International immunopharmacology, 2013, Volume: 17, Issue:2

    Topics: Animals; Blood Glucose; Caffeic Acids; Cells, Cultured; Diabetes Mellitus, Experimental; Endostatins; Humans; Insulin; Interferon-gamma; Interleukin-1beta; Islets of Langerhans; Male; Matrix Metalloproteinase 9; Mice; Neovascularization, Pathologic; Nitric Oxide; Phenylethyl Alcohol; Vesicular Transport Proteins

2013
The effects of caffeic acid phenethyl ester on streptozotocin-induced diabetic liver injury.
    Bratislavske lekarske listy, 2016, Volume: 117, Issue:5

    Topics: Animals; Caffeic Acids; Diabetes Mellitus, Experimental; Glutathione; Liver; Male; Malondialdehyde; NF-kappa B; Oxidative Stress; Phenylethyl Alcohol; Rats; Rats, Wistar; Superoxide Dismutase

2016
Caffeic acid phenethyl ester (CAPE) exhibits significant potential as an antidiabetic and liver-protective agent in streptozotocin-induced diabetic rats.
    Pharmacological research, 2009, Volume: 60, Issue:4

    Topics: Animals; Caffeic Acids; Diabetes Mellitus, Experimental; Glucose; Hypoglycemic Agents; Liver; Male; Phenylethyl Alcohol; Protective Agents; Rats; Rats, Wistar; Streptozocin

2009
Protective effect of caffeic acid phenethyl ester (CAPE) on lipid peroxidation and antioxidant enzymes in diabetic rat liver.
    Journal of biochemical and molecular toxicology, 2004, Volume: 18, Issue:4

    Topics: Animals; Antioxidants; Caffeic Acids; Catalase; Diabetes Mellitus, Experimental; Glutathione Peroxidase; Lipid Peroxidation; Liver; Male; Malondialdehyde; Phenylethyl Alcohol; Rats; Rats, Sprague-Dawley; Superoxide Dismutase

2004
Effects of caffeic acid phenethyl ester on lipid peroxidation and antioxidant enzymes in diabetic rat heart.
    Clinical biochemistry, 2005, Volume: 38, Issue:2

    Topics: Animals; Antioxidants; Caffeic Acids; Diabetes Mellitus, Experimental; Lipid Peroxidation; Male; Malondialdehyde; Myocardium; Oxidative Stress; Oxidoreductases; Phenylethyl Alcohol; Rats; Rats, Sprague-Dawley

2005
Caffeic acid phenethyl ester ameliorates changes in IGFs secretion and gene expression in streptozotocin-induced diabetic rats.
    Life sciences, 2006, Mar-06, Volume: 78, Issue:15

    Topics: Animals; Caffeic Acids; Diabetes Mellitus, Experimental; Gene Expression; Insulin-Like Growth Factor I; Insulin-Like Growth Factor II; Kidney; Liver; Male; Myocardium; Phenylethyl Alcohol; Protective Agents; Rats; Rats, Sprague-Dawley; RNA, Messenger

2006
Caffeic acid phenethyl ester (CAPE) protects brain against oxidative stress and inflammation induced by diabetes in rats.
    Molecular and cellular biochemistry, 2008, Volume: 312, Issue:1-2

    Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Brain; Caffeic Acids; Cytokines; Cytoprotection; Diabetes Mellitus, Experimental; Drug Evaluation, Preclinical; Encephalitis; Gene Expression Regulation; Lipid Peroxidation; Male; Neuroprotective Agents; Nitric Oxide; Oxidative Stress; Phenylethyl Alcohol; Rats; Rats, Wistar; Streptozocin

2008